Local Institution - 128 — Newark, New Jersey

Local Institution - 128 is a clinical research site located in Newark, New Jersey, United States 07112-2027.

Crixeo Health Trust Score: 47/100 (POOR). This profile has not yet been claimed by the site owner.

Local Institution - 128 has participated in 1 clinical trials.

Therapeutic areas: Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Myelofibrosis.

Sponsors: Celgene.

Sponsor Feasibility Report

Trust Score: 47/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 128?

Local Institution - 128 has a Crixeo Trust Score of 47/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 128 conducted?

Local Institution - 128 has 1 clinical trials on record. Their work covers Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Myelofibrosis.

Is Local Institution - 128 accredited by Crixeo Health?

Local Institution - 128 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 128?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.